SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-19-001010
Filing Date
2019-03-15
Accepted
2019-03-15 17:01:18
Documents
61
Period of Report
2019-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q thct_10q.htm 10-Q 278417
2 CERTIFICATION thct_ex311.htm EX-31.1 7804
3 CERTIFICATION thct_ex312.htm EX-31.2 7638
4 CERTIFICATION thct_ex321.htm EX-32.1 2775
5 CERTIFICATION thct_ex322.htm EX-32.2 3012
  Complete submission text file 0001477932-19-001010.txt   2600299

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT thct-20190131.xml EX-101.INS 458484
7 XBRL TAXONOMY EXTENSION SCHEMA thct-20190131.xsd EX-101.SCH 40169
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thct-20190131_cal.xml EX-101.CAL 43956
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thct-20190131_def.xml EX-101.DEF 136279
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE thct-20190131_lab.xml EX-101.LAB 200434
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thct-20190131_pre.xml EX-101.PRE 195457
Mailing Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135
Business Address 11700 W CHARLESTON BLVD #73 LAS VEGAS NV 89135 702-602-8422
THC Therapeutics, Inc. (Filer) CIK: 0001404935 (see all company filings)

IRS No.: 260164981 | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-55994 | Film No.: 19685750
SIC: 3523 Farm Machinery & Equipment